SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-22-083009
Filing Date
2022-12-28
Accepted
2022-12-27 20:42:52
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs12022a5_cadrenal.htm S-1/A 4567474
2 CONSENT OF WITHUMSMITH + BROWN, PC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR fs12022a5ex23-1_cadrenal.htm EX-23.1 2296
3 GRAPHIC tlogo_001.jpg GRAPHIC 63038
4 GRAPHIC tlinechart_001.jpg GRAPHIC 173392
5 GRAPHIC tflowchart_001.jpg GRAPHIC 213203
6 GRAPHIC tlinechart_002.jpg GRAPHIC 232334
7 GRAPHIC tlinechart_003.jpg GRAPHIC 155964
8 GRAPHIC tbarchart_001.jpg GRAPHIC 184805
9 GRAPHIC tbarchart_002.jpg GRAPHIC 214888
10 GRAPHIC tflowchart_002.jpg GRAPHIC 167409
  Complete submission text file 0001213900-22-083009.txt   6507043
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-267562 | Film No.: 221491532
SIC: 2834 Pharmaceutical Preparations